A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(27 sites)

China

Site01006, Beijing

Site01009, Beijing

Site01010, Beijing

Site01029, Bengbu

Site01020, Changsha